Filter News
Area of Research
News Topics
- (-) Energy Storage (2)
- (-) Isotopes (5)
- (-) Materials Science (3)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (7)
- Bioenergy (1)
- Biomedical (2)
- Computer Science (3)
- Coronavirus (1)
- Decarbonization (1)
- Fusion (6)
- Grid (1)
- Molten Salt (4)
- Neutron Science (3)
- Nuclear Energy (21)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
Media Contacts
Radioactive isotopes power some of NASA’s best-known spacecraft. But predicting how radiation emitted from these isotopes might affect nearby materials is tricky
A team led by Oak Ridge National Laboratory developed a novel, integrated approach to track energy-transporting ions within an ultra-thin material, which could unlock its energy storage potential leading toward faster charging, longer-lasting devices.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
To better determine the potential energy cost savings among connected homes, researchers at Oak Ridge National Laboratory developed a computer simulation to more accurately compare energy use on similar weather days.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.